https://www.channelnewsasia.com/world/new-drug-alzheimers-disease-us-fda-approves-leqembi-3188926
0
0
1/7/23 at 6:05am
Organization
CNA
Authors
WASHINGTON: The US Food and Drug Administration on Friday (Jan 6) approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease. The FDA approval of the drug, Leqembi, also known as lecan…
Create an account
or login to join the discussion